Newron Pharmaceuticals
NWRN.SW
#7831
Rank
A$0.51 B
Marketcap
A$24.57
Share price
-3.50%
Change (1 day)
57.04%
Change (1 year)

Half-year Reports

Thumbnail Newron Pharmaceuticals Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2018-h1

Half-year Report 2018-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2017-h1

Half-year Report 2017-h1

Language: English

View Half-year Report